{"transactions":[{"id":747599,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T20:36:53.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 4, 2027 and (ii) immediately prior to the 2027 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":90000,"derivative":{"exercise_price":2.96,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001376247-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000137624726000002/primarydocument.xml","form_type":"4"}},{"id":795090,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-05-04T21:09:24.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":false,"shares":1712,"price":70.81,"value":121226.72,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represent RSUs granted under the Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 3, 2025, the reporting person was granted 1,712 restricted stock units, all of which vested on May 1, 2026."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-01","underlying":"Common Stock","underlying_shares":1712},"source":{"system":"sec-edgar","filing":"0001225208-26-004883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520826004883/doc4.xml","form_type":"4"}},{"id":795089,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-04T21:09:24.000Z","date":"2026-05-01","kind":"exercise","planned":false,"acquired":true,"shares":1712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represent RSUs granted under the Non-Employee Director Compensation Program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."}],"balance_after":1712,"source":{"system":"sec-edgar","filing":"0001225208-26-004883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520826004883/doc4.xml","form_type":"4"}},{"id":797637,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-04-30T20:29:13.000Z","date":"2026-04-29","kind":"grant","planned":false,"acquired":true,"shares":2903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represent RSUs granted under the Non-Employee Director Compensation Program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs will vest on the one-year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs will vest on the one-year anniversary of the grant date."}],"balance_after":2903,"derivative":{"exercise_date":"2027-04-29","expiration_date":"2027-04-29","underlying":"Common Stock","underlying_shares":2903},"source":{"system":"sec-edgar","filing":"0001225208-26-004738","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520826004738/doc4.xml","form_type":"4"}},{"id":1009255,"issuer":{"id":3234,"kind":"organization","name":"INTERNATIONAL FLAVORS & FRAGRANCES INC"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-11-04T21:21:08.000Z","date":"2025-11-03","kind":"grant","planned":false,"acquired":true,"shares":1712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Restricted Stock Units (\"RSUs\") convert to Common Stock on a one-for-one basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest on May 1, 2026."}],"balance_after":1712,"derivative":{"exercise_date":"2026-05-01","underlying":"Common Stock","underlying_shares":1712},"source":{"system":"sec-edgar","filing":"0001225208-25-008915","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/51253/000122520825008915/doc4.xml","form_type":"4"}},{"id":1117525,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-09T20:40:01.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 5, 2026 and (ii) immediately prior to the 2026 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":80000,"derivative":{"exercise_price":2.55,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001562180-25-004644","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218025004644/primarydocument.xml","form_type":"4"}},{"id":1141163,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2025-05-20T20:29:29.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":54347,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":155616,"source":{"system":"sec-edgar","filing":"0001127602-25-015024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760225015024/form4.xml","form_type":"4"}},{"id":1398884,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-26T20:07:23.000Z","date":"2024-09-25","kind":"sale","planned":true,"acquired":false,"shares":150000,"price":3.8878,"value":583170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $4.13, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2698121,"source":{"system":"sec-edgar","filing":"0001562180-24-006954","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218024006954/primarydocument.xml","form_type":"4"}},{"id":1398883,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-26T20:07:23.000Z","date":"2024-09-24","kind":"sale","planned":true,"acquired":false,"shares":150000,"price":4.0838,"value":612570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.16, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2848121,"source":{"system":"sec-edgar","filing":"0001562180-24-006954","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218024006954/primarydocument.xml","form_type":"4"}},{"id":1454446,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-15T20:13:09.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4/A is being filed to correct a clerical error with regard to the number of option shares acquired."}],"balance_after":65000,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001562180-24-005723","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218024005723/primarydocument.xml","form_type":"4/A","original_submission_date":"2024-06-07"}},{"id":1486297,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:22:53.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":54278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 6, 2025 and (ii) immediately prior to the 2025 annual meeting of stockholders of Sana Biotechnology, Inc. (\"Sana\"), provided that the reporting person provides continuous service to Sana through such date."}],"balance_after":54278,"derivative":{"exercise_price":7.36,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":54278},"source":{"system":"sec-edgar","filing":"0001562180-24-004845","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218024004845/primarydocument.xml","form_type":"4"}},{"id":1509680,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2024-05-20T21:53:48.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":35360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":101269,"source":{"system":"sec-edgar","filing":"0001127602-24-016031","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760224016031/form4a.xml","form_type":"4/A","original_submission_date":"2024-05-20"}},{"id":1885833,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2023-05-19T20:16:54.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":29205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":65909,"source":{"system":"sec-edgar","filing":"0001127602-23-016290","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760223016290/form4.xml","form_type":"4"}},{"id":1972201,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of SanaX"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-03-03T21:32:29.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 2, 2024 and in 36 equal monthly installments thereafter."}],"balance_after":200000,"derivative":{"exercise_price":3.76,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-23-002394","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218023002394/primarydocument.xml","form_type":"4"}},{"id":2220532,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-06-28T20:35:39.000Z","date":"2022-06-24","kind":"grant","acquired":true,"shares":34387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted share units (\"RSUs\") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer."}],"balance_after":36704,"source":{"system":"sec-edgar","filing":"0001127602-22-018200","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222018200/form4.xml","form_type":"4"}},{"id":2228922,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-17T21:03:54.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":1370,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15099,"source":{"system":"sec-edgar","filing":"0001127602-22-017797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760222017797/form4.xml","form_type":"4"}},{"id":2269251,"issuer":{"id":4363,"kind":"organization","name":"Bausch Health Companies Inc."},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Shares, No Par Value","published_at":"2022-05-17T22:04:08.000Z","date":"2022-05-13","kind":"grant","acquired":true,"shares":2317,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Share Units (\"RSUs\"), each representing a contingent right to receive one Common Share, no par value, of Bausch Health Companies Inc., which will vest immediately before the 2022 Annual Meeting of\nShareholders."}],"balance_after":2317,"source":{"system":"sec-edgar","filing":"0001127602-22-014807","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/885590/000112760222014807/form4.xml","form_type":"4"}},{"id":2343858,"issuer":{"id":4870,"kind":"organization","name":"Sana Biotechnology, Inc.","symbol":"SANA"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of SanaX"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-03-08T14:06:35.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable as to 25% of the underlying shares on March 3, 2023 and in 36 equal monthly installments thereafter."}],"balance_after":250000,"derivative":{"exercise_price":5.7,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001562180-22-002428","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376247/000156218022002428/primarydocument.xml","form_type":"4"}},{"id":2646239,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-02T21:30:52.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13729,"source":{"system":"sec-edgar","filing":"0001127602-21-021341","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760221021341/form4.xml","form_type":"4"}},{"id":3121175,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-05T21:17:59.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":890,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12954,"source":{"system":"sec-edgar","filing":"0001127602-20-019027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220019027/form4.xml","form_type":"4"}},{"id":3483322,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-06-20T21:51:23.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":1155,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12064,"source":{"system":"sec-edgar","filing":"0001127602-19-022420","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219022420/form4.xml","form_type":"4"}},{"id":3894740,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-14T21:32:34.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":880,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10909,"source":{"system":"sec-edgar","filing":"0001127602-18-020962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218020962/form4.xml","form_type":"4"}},{"id":4287717,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":40830,"kind":"person","name":"Mulligan Richard","position":1,"cik":"0001376247","reported_name":"Mulligan Richard","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-06-09T21:55:33.000Z","date":"2017-06-07","kind":"grant","acquired":true,"shares":1055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On 6/8/16 an RSU was awarded for 1,060 shares.  This award was adjusted to 1,084 shares pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017."}],"balance_after":10029,"source":{"system":"sec-edgar","filing":"0001127602-17-021103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760217021103/form4.xml","form_type":"4"}}]}